Last reviewed · How we verify
Nosocomial Pneumonia due to Serratia Marcescens
Approved treatments
- Noroxin
- Floxin
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Nosocomial Pneumonia due to Serratia Marcescens patent landscape — cliff calendar, originator estates, attackable patents
- Nosocomial Pneumonia due to Serratia Marcescens treatment landscape brief
- Nosocomial Pneumonia due to Serratia Marcescens treatment updates RSS
Frequently asked questions about Nosocomial Pneumonia due to Serratia Marcescens
What drugs treat Nosocomial Pneumonia due to Serratia Marcescens?
Tracked treatments include Noroxin, Floxin, Levaquin, Ofloxacine.
What is the treatment for Nosocomial Pneumonia due to Serratia Marcescens?
Standard treatment for Nosocomial Pneumonia due to Serratia Marcescens includes Noroxin, Floxin, Levaquin, Ofloxacine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Nosocomial Pneumonia due to Serratia Marcescens patent cliff · Nosocomial Pneumonia due to Serratia Marcescens CI report
- Treatment: Noroxin
- Treatment: Floxin
- Treatment: Levaquin · Generic (originally Daiichi Sankyo/J&J)
- Treatment: Ofloxacine · Assistance Publique - Hôpitaux de Paris
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing